Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Shares Outstanding (Diluted Average) (2017 - 2025)

OptimizeRx's Shares Outstanding (Diluted Average) history spans 15 years, with the latest figure at $19.5 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) rose 6.62% year-over-year to $19.5 million; the TTM value through Sep 2025 reached $19.5 million, up 6.62%, while the annual FY2024 figure was $18.3 million, 6.82% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q3 2025 was $19.5 million at OptimizeRx, up from $19.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $19.5 million in Q3 2025 and bottomed at $16.1 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Diluted Average) is $18.0 million (2022), against an average of $17.8 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) increased 23.68% in 2021 before it dropped 7.54% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $17.7 million in 2021, then rose by 0.53% to $17.8 million in 2022, then dropped by 3.71% to $17.1 million in 2023, then increased by 6.82% to $18.3 million in 2024, then grew by 6.38% to $19.5 million in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Shares Outstanding (Diluted Average) are $19.5 million (Q3 2025), $19.0 million (Q2 2025), and $18.5 million (Q1 2025).